Table 2.
CD4+ T-cells | Yeara | Estimateb | 95% CIc | p-Value | |
---|---|---|---|---|---|
ANTI-TAT HUMORAL RESPONSE | |||||
IgM+, IgG+, and IgA+ | 1 | 32 | −32 | 96 | 0.3246 |
2 | 101 | 10 | 192 | 0.0296 | |
3 | 89 | −19 | 197 | 0.1078 | |
4 | 117 | 0 | 233 | 0.0492 | |
5 | 194 | 79 | 309 | 0.0009 | |
6 | 145 | 34 | 257 | 0.0106 | |
7 | 79 | −26 | 183 | 0.1420 | |
8+ | 75 | −20 | 169 | 0.1221 | |
IgM+/IgG+ or IgG+/IgA+ or IgM+/IgA+ | 1 | 50 | −15 | 115 | 0.1293 |
2 | 53 | −21 | 127 | 0.1575 | |
3 | 30 | −28 | 88 | 0.3071 | |
4 | 175 | 42 | 309 | 0.0099 | |
5 | 179 | 44 | 313 | 0.0092 | |
6 | 140 | 41 | 239 | 0.0058 | |
7 | 95 | −1 | 192 | 0.0528 | |
8+ | 69 | −20 | 158 | 0.1277 | |
IgM+ or IgG+ or IgA+ | 1 | 13 | −34 | 61 | 0.5818 |
2 | 55 | −7 | 117 | 0.0815 | |
3 | 2 | −126 | 130 | 0.9771 | |
4 | 63 | −4 | 131 | 0.0661 | |
5 | 162 | 79 | 246 | 0.0001 | |
6 | 88 | 12 | 164 | 0.0241 | |
7 | 65 | −62 | 193 | 0.3148 | |
8+ | −57 | −198 | 85 | 0.4311 | |
Ab Negative | 1 | 55 | −7 | 117 | 0.0834 |
2 | 72 | −32 | 175 | 0.1745 | |
3 | 38 | −35 | 110 | 0.3090 | |
4 | 118 | −24 | 261 | 0.1039 | |
5 | 116 | 33 | 199 | 0.0062 | |
6 | 137 | 38 | 235 | 0.0064 | |
7 | 132 | 24 | 239 | 0.0162 | |
8+ | 211 | 91 | 332 | 0.0006 | |
VACCINE TREATMENT GROUPS | |||||
Tat 7.5 μg, 3 × | 1 | −7 | −53 | 39 | 0.7597 |
2 | 22 | −33 | 76 | 0.4383 | |
3 | 10 | −89 | 109 | 0.8417 | |
4 | 36 | −79 | 152 | 0.5352 | |
5 | 115 | 15 | 216 | 0.0246 | |
6 | 93 | −3 | 189 | 0.0565 | |
7 | 59 | −43 | 161 | 0.2558 | |
8+ | 68 | −26 | 162 | 0.1557 | |
Tat 7.5 μg, 5 × | 1 | 67 | −18 | 152 | 0.1240 |
2 | 129 | −12 | 270 | 0.0738 | |
3 | 46 | −46 | 138 | 0.3293 | |
4 | 135 | 33 | 237 | 0.0096 | |
5 | 149 | 47 | 251 | 0.0044 | |
6 | 124 | 24 | 224 | 0.0154 | |
7 | 91 | −30 | 212 | 0.1410 | |
8+ | 64 | −54 | 182 | 0.2904 | |
Tat 30 μg, 3 × | 1 | 65 | 17 | 112 | 0.0080 |
2 | 69 | 10 | 128 | 0.0227 | |
3 | 27 | −44 | 98 | 0.4547 | |
4 | 197 | 80 | 314 | 0.0009 | |
5 | 222 | 117 | 327 | <0.0001 | |
6 | 130 | 42 | 218 | 0.0039 | |
7 | 128 | 28 | 228 | 0.0122 | |
8+ | 78 | −12 | 168 | 0.0905 | |
Tat 30 μg, 5 × | 1 | 26 | −31 | 84 | 0.3712 |
2 | 62 | −10 | 135 | 0.0932 | |
3 | 75 | −5 | 156 | 0.0663 | |
4 | 105 | −16 | 226 | 0.0877 | |
5 | 165 | 60 | 270 | 0.0020 | |
6 | 162 | 54 | 271 | 0.0032 | |
7 | 93 | −7 | 194 | 0.0684 | |
8+ | 89 | −16 | 194 | 0.0983 | |
VIRAL LOAD | |||||
At least 90% visits with 0 copies | 1 | 60 | −22 | 142 | 0.1517 |
2 | 84 | −5 | 174 | 0.0653 | |
3 | 46 | −47 | 139 | 0.3331 | |
4 | 163 | 12 | 313 | 0.0343 | |
5 | 234 | 93 | 375 | 0.0011 | |
6 | 134 | 25 | 243 | 0.0162 | |
7 | 92 | −5 | 189 | 0.0632 | |
8+ | 63 | −21 | 148 | 0.1389 | |
Less than 90% visits with 0 copies | 1 | 15 | −9 | 39 | 0.2142 |
2 | 56 | 8 | 105 | 0.0215 | |
3 | 33 | −22 | 89 | 0.2372 | |
4 | 74 | 32 | 117 | 0.0006 | |
5 | 92 | 53 | 131 | <0.0001 | |
6 | 121 | 70 | 171 | <0.0001 | |
7 | 94 | 30 | 157 | 0.0037 | |
8+ | 86 | 15 | 156 | 0.0172 | |
ARV REGIMENS | |||||
NNRTI- or NRTI-based | 84 | 41 | 126 | 0.0001 | |
PI-based | 97 | 33 | 161 | 0.0029 |
Year since first immunization;
Least square means;
Confidence interval.
Multivariate analysis of variance for repeated measures of longitudinal samples from 92 individuals.